American Gene Technologies International americangene.com


Public lists: Pharma Startups (6570)

American Gene Technologies is developing and commercializing genetic medicines targeting major diseases, including HIV/AIDS, Phenylketonuria (PKU) and Hepatocellular carcinoma (liver cancer, or HCC).

American Gene Technologies is developing and commercializing genetic medicines targeting major diseases, including HIV/AIDS, Phenylketonuria (PKU) and Hepatocellular carcinoma (liver cancer, or HCC).

Company (Alive / Active)

All investors data 2 Investors

Phone: 301-337-2100

Fax:

9640 Medical Center Drive

 Rockville, 20850
 Maryland, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
American Gene Technologies International $2.8M Feb 20, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related American Gene Technologies International Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Methods and compositions for the activation of gamma-delta t-cells Jul 17, 2017 Mar 13, 2018 Patent
Methods and compositions for the activation of gamma-delta t-cells Dec 21, 2017 Application
Methods and compositions for the activation of gamma-delta t-cells Dec 20, 2017 Application
Hiv pre-immunization and immunotherapy Aug 03, 2017 Application